Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,393,592 papers from all fields of science
Search
Sign In
Create Free Account
mercaptopurine/methotrexate/prednisone/vincristine protocol
Known as:
POMP protocol
, MP/MTX/PRED/VCR
, Mercaptopurine/Methotrexate/Prednisone/Vincristine
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (4)
Antineoplastic Combined Chemotherapy Protocols
Methotrexate
cisplatin/cyclophosphamide/etoposide protocol
mercaptopurine
Prednisone
Vincristine
mercaptopurine/methotrexate/methylprednisolone/vincristine protocol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
E. Jabbour
,
Guillaume Richard-Carpentier
,
+30 authors
H. Kantarjian
The Lancet Haematology
2020
Corpus ID: 220122928
2013
2013
Phase II Study Of The Hyper-CVAD Regimen In Combination With Ofatumumab As Frontline Therapy For Adults With CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
E. Jabbour
,
H. Kantarjian
,
+8 authors
S. O'brien
2013
Corpus ID: 208489499
Background The hyper-CVAD regimen is an effective frontline program for de novo adult ALL. Expression of CD20 was identified as…
Expand
2007
2007
Transmission of Mouse Minute Virus (MMV) but Not Mouse Hepatitis Virus (MHV) Following Embryo Transfer with Experimentally Exposed In Vivo-Derived Embryos1
E. Mahabir
,
D. Bulian
,
+5 authors
Jörg C. Schmidt
Biology of Reproduction
2007
Corpus ID: 11484997
Abstract The present study investigated the presence and location of fluorescent microspheres having the size of mouse hepatitis…
Expand
2006
2006
Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation.
M. Hoefer
,
E. Boneberg
,
Stefan Grotegut
,
J. Kusch
,
H. Illges
International Journal of Biological…
2006
Corpus ID: 9391382
Review
2004
Review
2004
Mouse antibody production test: can we do without it?
E. Mahabir
,
K. Jacobsen
,
M. Brielmeier
,
D. Peters
,
J. Needham
,
J. Schmidt
Journal of Virological Methods
2004
Corpus ID: 38276445
1992
1992
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction…
Francis S. Morrison
,
K. Kopecky
,
+7 authors
John H. Saiki
Leukemia
1992
Corpus ID: 38412533
Between August 1978 and September 1982, 642 patients with newly diagnosed acute myelogenous leukemia (AML) were entered onto a…
Expand
1991
1991
In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate.
P. Wallace
,
P. Senter
Bioconjugate chemistry
1991
Corpus ID: 32603033
The prodrug p-[N,N-bis(2-chloroethyl)amino]phenyl phosphate (phenol mustard phosphate, POMP) was prepared from p-[N,N-bis(2…
Expand
Highly Cited
1987
Highly Cited
1987
Role of maintenance chemotherapy in acute promyelocytic leukemia
H. Kantarjian
,
M. Keating
,
R. Walters
,
T. Smith
,
K. McCredie
,
E. Freireich
Cancer
1987
Corpus ID: 25131586
The effect of maintenance chemotherapy on remission duration was analyzed in 39 of 70 patients (56%) with acute promyelocytic…
Expand
1976
1976
Acute myelogenous leukemia in children: a preliminary report of combination chemotherapy.
P. Pizzo
,
E. Henderson
,
B. Leventhal
Jornal de Pediatria
1976
Corpus ID: 9452215
1975
1975
Comparison of prednisolone, vincristine, methotrexate, and 6‐mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia
D. Berry
,
J. Pullen
,
S. George
,
T. Vietti
,
M. Sullivan
,
D. Fernbach
Cancer
1975
Corpus ID: 45235290
This study was designed to compare vincristine‐prednisone (VP) vs. prednisolone, vincristine, methotrexate, and 6‐mercaptopurine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE